Compare GDS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDS | ELAN |
|---|---|---|
| Founded | 2001 | 1954 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.3B |
| IPO Year | N/A | N/A |
| Metric | GDS | ELAN |
|---|---|---|
| Price | $45.19 | $24.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $46.20 | $24.44 |
| AVG Volume (30 Days) | 2.4M | ★ 4.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.03 | $7.25 |
| Revenue Next Year | $12.55 | $5.80 |
| P/E Ratio | ★ $52.75 | $351.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.93 | $8.02 |
| 52 Week High | $52.50 | $26.08 |
| Indicator | GDS | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 55.13 | 55.48 |
| Support Level | $44.27 | $24.76 |
| Resistance Level | $48.61 | $26.08 |
| Average True Range (ATR) | 2.42 | 0.71 |
| MACD | -0.19 | -0.03 |
| Stochastic Oscillator | 56.33 | 47.81 |
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.